NFKB1 and Alzheimer disease: This activity of NF-κB remains enhanced and associated during the inflammatory condition and shows its predominant expression in peripheral blood mononuclear cells (PBMCs) and in the brain of AD patients, which is proposed as a significant marker for the progression of AD (Juźwik et al., 2019).